4//SEC Filing
BONDURANT STUART 4
Accession 0001181152-11-000001
CIK 0001003124other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:27 PM ET
Size
13.1 KB
Accession
0001181152-11-000001
Insider Transaction Report
Form 4
BONDURANT STUART
Director
Transactions
- Award
Common Stock
2011-01-03+2,355→ 20,199 total
Holdings
- 14,053
Stock Options (to buy)
Exercise: $19.19From: 2009-05-20Exp: 2019-05-20→ Common Stock (14,053 underlying) - 6,485
Stock Options (to buy)
Exercise: $41.32From: 2008-05-21Exp: 2018-05-20→ Common Stock (6,485 underlying) - 5,650
Stock Options (to buy)
Exercise: $22.98From: 2005-05-18Exp: 2015-05-17→ Common Stock (5,650 underlying) - 6,341
Stock Options (to buy)
Exercise: $32.67From: 2007-05-16Exp: 2017-05-16→ Common Stock (6,341 underlying) - 10,496
Stock Options (to buy)
Exercise: $24.52From: 2010-05-20Exp: 2020-05-20→ Common Stock (10,496 underlying) - 4,113
Stock Options (to buy)
Exercise: $34.18From: 2006-05-17Exp: 2016-05-16→ Common Stock (4,113 underlying)
Footnotes (1)
- [F1]Exercise price and share amounts reflect an anti-dilution adjustment made in connection with the June 14, 2010 spin-off of Furiex Pharmaceuticals, Inc.
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeother
Related Parties
1- filerCIK 0001181152
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:27 PM ET
- Size
- 13.1 KB